Tests:CA 15-3: Difference between revisions
Tests:CA 15-3
Created page with "{{DISPLAYTITLE: CA 15-3}} Full Test List Biochemistry Tests {| class="wikitable" ! colspan="2" | ===''Overview''=== |- |Department |Biochemistry |- |Test Code | |- |Synonyms |C153 C15-3 CA153 |- |Turnaround Time |1 – 4 days |- |Stability – Add test | |- ! colspan="2" | ===''Specimen Requirements''=== |- |Specimen Type |7mL <span style="background:#e30022"> red top </span> or SST <span style="background: #fbec5d"> yellow top</span> |- |Specimen T..." |
No edit summary |
||
| (8 intermediate revisions by 4 users not shown) | |||
| Line 5: | Line 5: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Overview == | ||
|- | |- | ||
|Department | |Department | ||
| Line 11: | Line 11: | ||
|- | |- | ||
|Test Code | |Test Code | ||
| | |CA153 | ||
|- | |- | ||
|Synonyms | |Synonyms | ||
| Line 19: | Line 19: | ||
CA153 | CA153 | ||
|- | |||
|Availability | |||
|Tested Monday, Wednesday and Friday afternoons. | |||
Please contact the laboratory if testing is required urgently | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
| Line 24: | Line 28: | ||
|- | |- | ||
|Stability – Add test | |Stability – Add test | ||
| | |24 hours | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |||
|Specimen | |||
|Serum | |||
|- | |- | ||
| | |Preferred | ||
| | |<span style="background: #fbec5d">Yellow-Top</span> SST or <span style="background:#e30022">Red-Top </span> tube | ||
|- | |- | ||
| | |Acceptable | ||
| | | | ||
|- | |- | ||
| | |Unacceptable | ||
| | |Plasma | ||
|- | |- | ||
| | |Specimen Transportation | ||
| | | | ||
|- | |- | ||
| | |Paediatric Requirements | ||
|0.5 <span style="background:#e30022"> | |0.5 mL <span style="background:#e30022"> Red </span> microtainer | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |- | ||
|Sample | |Sample | ||
|>500 uL | |Serum | ||
|- | |||
|Preferred Volume | |||
|>500 uL | |||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
|200 uL | |200 uL | ||
|- | |- | ||
|Aliquot Transportation | |Aliquot Transportation | ||
| Line 57: | Line 67: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Clinical Information == | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 63: | Line 73: | ||
|- | |- | ||
|Test Method | |Test Method | ||
|Abbott | |Abbott Alinity i series analyser using Abbott reagents. Chemiluminescent microparticle immunoassay. | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
| Line 74: | Line 82: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Comments == | ||
|- | |- | ||
| colspan="2" | | | colspan="2" |Ca 15-3 is particularly useful for monitoring breast cancer. | ||
Ca 15-3 is particularly useful for monitoring breast | |||
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | ||
|} | |} | ||
{{DocMeta | |||
| owner = Crossley1 | |||
| review_ping = | |||
}} | |||
<!-- review-ping: 2026-09-14T07:48:17.510Z --> | |||